Dario Eklund joined Santhera as Chief Executive Officer (CEO) and member of Santhera’s Executive Management Team effective December 1, 2019. Prior to his new role at Santhera, he served as Chief Commercial Officer of Vifor Pharma with full P&L responsibility for a global business with turnover in excess of CHF 1 billion and more than 1’000 employees. He was a member of Vifor’s Corporate Executive Committee and a member of the Board of Directors of the joint venture with Fresenius Medical Care (Vifor Fresenius Medical Care Renal Pharma). Before Vifor, Dario spent a decade in Boston as Vice President and a member of the Executive Committee at Organogenesis Inc., a Nasdaq-listed world leading company in regenerative medicine and cell therapy with three approved products. During his time the company experienced strong growth and rapid expansion with sales coming from Europe and USA (annual growth rates of 20-25% over a decade). He started his career with various roles in sales, global marketing, business development and general management at Novartis and Sanofi in a number of territories.
Dario holds a M.Sc. (Econ) and graduated from the Swedish School of Economics and Business Administration in Helsinki, Finland.